Toluene diisocyanate produces an increase in airway tone that outlasts the inflammatory exudation phase.
Toluene diisocyanate (TDI) is a causative agent in occupational asthma. Through an oral catheter TDI, 0.03 microliters, dissolved in 0.02 ml olive oil, was superfused on the tracheobronchial mucosa of anaesthetized guinea-pigs. TDI induced plasma exudation into both airway tissue and lumen (peak effect: 5 hr; duration approximately 17 hr). Light microscopy examinations demonstrated that the epithelium was not disrupted by this process (and that microvessels are abundant just beneath the epithelium). At days 6 and 21 after exposure to TDI PAS-positive cells were increased, but no other histological alterations were found. Also, the occurrence of peptide-containing nerve fibres was not altered by TDI. After TDI-exposure the airway smooth muscle tone was elevated as examined in vitro at base-line and at concentration-response to carbachol. The largest increases in tone were recorded 21 days after exposure to TDI. The abnormally large tone was not associated with an increased thickness of the smooth muscle layer nor was it associated with reduced effects of either beta 2-agonist (terbutaline) or xanthine- (theophylline) relaxants. It is concluded that TDI-induced plasma exudation into guinea-pig airways occurs for 17 hr without disrupting the epithelial lining and without causing major changes in the airway peptidergic innervation. Both the airway tone, and the number of mucous cells, are increased for at least 3 weeks after exposure to TDI.
Persson
C G
CG
Department of Clinical Pharmacology, University Hospital of Lund, Sweden.
Gustafsson
B
B
Luts
A
A
Sundler
F
F
Erjefält
I
I
D000403:Airway Resistance / Q000187:drug effects*; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D005122:Exudates and Transudates; D006168:Guinea Pigs; D007249:Inflammation; D008297:Male; D009092:Mucous Membrane / Q000187:drug effects / Q000473:pathology; D009130:Muscle, Smooth / Q000187:drug effects / Q000503:physiopathology; D013726:Terbutaline / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D014051:Toluene 2,4-Diisocyanate / Q000494:pharmacology* / Q000633:toxicity; D014132:Trachea / Q000187:drug effects* / Q000473:pathology
D014051:Toluene 2,4-Diisocyanate; D002217:Carbachol; D013806:Theophylline; D013726:Terbutaline